beta

CRBP

Corbus Pharmaceuticals Holdings Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage company focused on the development and commercialization of novel medicines designed to target the endocannabinoid system. The Company's lead product candidate, lenabasum, is a novel, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to provide an alternative to immunosuppressive medications in the treatment of chronic inflammatory and fibrotic diseases. Lenabasum is currently being evaluated in dermatomyositis and systemic lupus erythematosus. Corbus is also developing a pipeline of other preclinical drug candidates from its endocannabinoid system platform.

Market Cap: 268 Million

Primary Exchange: NASDAQ/NMS (GLOBAL MARKET)

Website: www.corbuspharma.com

Shares Outstanding: 125 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 2.66980698905192

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 1160 trading days

From: 2017-03-20 To: 2021-06-15

Lowest Point:

Corbus up 3% premarket on positive lenabasum data in rare autoimmune disorders

via: SeekingAlpha at 2019-06-12 04:44:17:000

Corbus Pharmaceuticals (NASDAQ: CRBP ) perks up 3% premarket on light volume in response to longer term data on lenabasum in mid-stage studies in systemic sclerosis (SSc) and dermatomyositis (DM). The results are being presented at EULAR in Madrid. More news on: Corbus Pharma… read more...

Corbus up 3% premarket on positive lenabasum data in rare autoimmune disorders

via: SeekingAlpha at 2019-06-12 04:44:17:000

Corbus Pharmaceuticals (NASDAQ: CRBP ) perks up 3% premarket on light volume in response to longer term data on lenabasum in mid-stage studies in systemic sclerosis (SSc) and dermatomyositis (DM). The results are being presented at EULAR in Madrid. More news on: Corbus Pharma… read more...

Robbins Arroyo LLP: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Sued for Misleading Shareholders

via: Business Wire at 2019-06-10 14:39:00:000

Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) filed a class action complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between November 14, 2016 and Feb… read more...

Robbins Arroyo LLP: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Sued for Misleading Shareholders

via: Business Wire at 2019-06-10 14:39:00:000

Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) filed a class action complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between November 14, 2016 and Feb… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud